Last reviewed · How we verify

A 12-Week, Randomized, Double-Blind, Corn Oil-Controlled Phase 3 Study to Assess the Efficacy and Safety of Omega-3-Acid Ethyl Esters 90 Soft Capsules in Subjects With Severe Hypertriglyceridemia (OMEELVHT)

NCT02625870 Phase 3 UNKNOWN

The trial was a double-blind, randomized, parallel-group study comparing Omega-3-Acid Ethyl Esters 90 Soft Capsules and placebo. The primary objective of the present study was to evaluate the efficacy and safety of Omega-3-Acid Ethyl Esters 90 Soft Capsules in subjects with severe hypertriglyceridemia (TGs ≥500 mg/dL but \<2000 mg/dL).

Details

Lead sponsorJiangsu HengRui Medicine Co., Ltd.
PhasePhase 3
StatusUNKNOWN
Enrolment240
Start date2015-12

Conditions

Interventions

Primary outcomes